0.00Open22.10Pre Close0 Volume0 Open Interest50.00Strike Price0.00Turnover2896.67%IV-1.35%PremiumMay 17, 2024Expiry Date23.09Intrinsic Value100Multiplier-5DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type0.9581Delta0.0054Gamma3.31Leverage Ratio-31.0249Theta0.0000Rho3.17Eff Leverage0.0005Vega
Ormat Technologies Stock Discussion
Apple has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $116 to $210.
Citigroup Upgrades $Norfolk Southern(NSC.US)$to Buy From Neutral, Adjusts Price Target to $257 From $226
Norfolk Southern has an average rating of outperform and price targets ranging from $174 to $288, according to analysts ...
Gap Ups
1. $Bath & Body Works(BBWI.US)$ - up 7.8%
2. $Lloyds Banking(LYG.US)$ - up 0.48%
3. $Cisco(CSCO.US)$ - up 0.4%
Gap Downs
1. $Ormat Technologies(ORA.US)$ - down 5.45%
2. $Cloudflare(NET.US)$ - down 3.46%
3. $Spotify Technology(SPOT.US)$ - down 2.62%
4. $Gitlab(GTLB.US)$ - dow...
• $La-Z-Boy(LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer(PFE.US)$)
• $Ikena Oncology(IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
No comment yet